{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:18:25Z","timestamp":1778725105254,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.resmer.2025.101165","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:27:51Z","timestamp":1741710471000},"page":"101165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension associated with COPD: A systematic literature review"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7762-3845","authenticated-orcid":false,"given":"Beatrice","family":"Le Bon Chami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-1778","authenticated-orcid":false,"given":"Fida","family":"Charif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Semaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1348-9119","authenticated-orcid":false,"given":"Vanessa","family":"Bironneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Larrieu-Ardilouze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-9915","authenticated-orcid":false,"given":"Magali","family":"Croquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-7994","authenticated-orcid":false,"given":"Xavier","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-7523","authenticated-orcid":false,"given":"Lucilla","family":"Piccari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-6922","authenticated-orcid":false,"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne-Marie","family":"Jutant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2025.101165_bib0001","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/COPD.S359873","article-title":"The incidence and prevalence of pulmonary hypertension in the COPD population: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.resmer.2025.101165_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0003","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0004","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2147\/COPD.S211841","article-title":"Updated perspectives on pulmonary hypertension in COPD","volume":"15","author":"Blanco","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.resmer.2025.101165_bib0005","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"Thabut","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2025.101165_bib0006","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101165_bib0007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.chest.2022.01.031","article-title":"Severe pulmonary hypertension in COPD","volume":"162","author":"Kovacs","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2025.101165_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107412","article-title":"Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: analysis of exacerbations and healthcare resource utilization in the United States","volume":"219","author":"Klinger","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2025.101165_bib0009","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: results from the ASPIRE registry","volume":"41","author":"Hurdman","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0011","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chest.2021.02.012","article-title":"Pulmonary hypertension in patients with COPD","volume":"160","author":"Vizza","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2025.101165_bib0012","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00944-2021","article-title":"Elevated pulmonary vascular resistance predicts mortality in COPD patients","volume":"58","author":"Zeder","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0013","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00172-2024","article-title":"Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results","author":"Nathan","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0014","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1755-5922.2011.00279.x","article-title":"ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension","volume":"30","author":"Badesch","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.resmer.2025.101165_bib0016","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pupt.2005.09.006","article-title":"Sildenafil improves hemodynamic parameters in COPD\u2014An investigation of six patients","volume":"19","author":"Alp","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.resmer.2025.101165_bib0017","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1183\/09031936.00114207","article-title":"Sildenafil treatment in COPD does not affect stroke volume or exercise capacity","volume":"31","author":"Rietema","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0018","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ejcdt.2016.05.005","article-title":"Sildenafil citrate therapy for secondary pulmonary arterial hypertension due to chronic obstructive lung disease","volume":"65","author":"Alkhayat","year":"2016","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"10.1016\/j.resmer.2025.101165_bib0019","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/689291","article-title":"The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease","volume":"7","author":"Bajwa","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.resmer.2025.101165_bib0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2016.04.010","article-title":"Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial","volume":"36","author":"Vitulo","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.resmer.2025.101165_bib0022","first-page":"271","article-title":"Effect of Sildenafil citrate on pulmonary arterial systolic pressure and sub-maximal exercise capacity in chronic obstructive pulmonary disease","volume":"15","author":"Shrestha","year":"2017","journal-title":"Kathmandu Univ Med J KUMJ"},{"key":"10.1016\/j.resmer.2025.101165_bib0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-2600(14)70013-X","article-title":"Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial","volume":"2","author":"Goudie","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resmer.2025.101165_bib0024","doi-asserted-by":"crossref","first-page":"e12043","DOI":"10.1002\/pul2.12043","article-title":"Tadalafil for veterans with chronic obstructive pulmonary disease\u2014Pulmonary hypertension: a multicenter, placebo-controlled randomized trial","volume":"12","author":"Maron","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.resmer.2025.101165_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1753465808103499","article-title":"Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease","volume":"3","author":"Valerio","year":"2009","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.resmer.2025.101165_bib0026","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.00176312","article-title":"Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial","volume":"42","author":"Blanco","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0027","first-page":"81","article-title":"Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial","volume":"53","author":"Rao","year":"2011","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"10.1016\/j.resmer.2025.101165_bib0028","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02445-2018","article-title":"Riociguat for treatment of pulmonary hypertension in COPD: a translational study","volume":"53","author":"Pichl","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0029","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.16520","article-title":"Role of selexipag in chronic obstructive pulmonary disease (COPD) patients with out-of-proportion pulmonary hypertension","author":"Abuserewa","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.resmer.2025.101165_bib0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/resp.12530","article-title":"Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases","volume":"20","author":"Tanabe","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.resmer.2025.101165_bib0031","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000441304","article-title":"Pulmonary arterial hypertension-specific drug therapy in COPD patients with severe Pulmonary hypertension and mild-to-moderate airflow limitation","volume":"91","author":"Calcaianu","year":"2016","journal-title":"Respiration"},{"key":"10.1016\/j.resmer.2025.101165_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107585","article-title":"Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype","volume":"225","author":"Steger","year":"2024","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2025.101165_bib0033","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00408-014-9650-1","article-title":"Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis","volume":"192","author":"Fossati","year":"2014","journal-title":"Lung"},{"key":"10.1016\/j.resmer.2025.101165_bib0034","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000431380","article-title":"Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy","volume":"90","author":"Girard","year":"2015","journal-title":"Respiration"},{"key":"10.1016\/j.resmer.2025.101165_bib0035","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1183\/13993003.02307-2014","article-title":"Severe pulmonary hypertension in lung disease: phenotypes and response to treatment","volume":"46","author":"Brewis","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0036","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1253\/circj.CJ-20-0939","article-title":"Multi-institutional prospective cohort study of patients with pulmonary hypertension associated with Respiratory diseases","volume":"85","author":"Tanabe","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.resmer.2025.101165_bib0037","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate Therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2025.101165_bib0038","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1111\/bcp.14676","article-title":"Riociguat: clinical research and evolving role in therapy","volume":"87","author":"Klinger","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.resmer.2025.101165_bib0039","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2025.101165_bib0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1164\/rccm.200907-0988OC","article-title":"Hemodynamic and gas exchange effects of Sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"181","author":"Blanco","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101165_bib0042","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00463-2023","article-title":"Mechanisms of hypoxaemia in severe pulmonary hypertension associated with COPD","volume":"62","author":"Piccari","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0043","doi-asserted-by":"crossref","first-page":"PA3500","DOI":"10.1183\/13993003.congress-2023.PA3500","article-title":"Effect of targeted pulmonary arterial hypertension therapy on arterial oxygenation in patients with pulmonary hypertension associated with lung disease: a systematic review and meta-analysis","author":"Blanco","year":"2023","journal-title":"Pulm. Hypertens., Eur Respiratory Soc"},{"key":"10.1016\/j.resmer.2025.101165_bib0044","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01200-2024","article-title":"Pulmonary hypertension associated with lung diseases","author":"Shlobin","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101165_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1183\/09059180.00006213","article-title":"The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension","volume":"22","author":"Gaine","year":"2013","journal-title":"Eur Respir Rev"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:34:29Z","timestamp":1748518469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041225000121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"alternative-id":["S2590041225000121"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101165","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension associated with COPD: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101165"}}